Nitric oxide modulates lipopolysaccharide-induced endothelial platelet endothelial cell adhesion molecule expression via interleukin-10

Clinical and Experimental Immunology

Volumn 165, Issue 2, 2011, Pages 172-179

  Hebeda, C B ^a   Teixeira, S A ^a   Tamura, E K ^a   Muscara M N ^a   de Mello, S B V ^a   Markus, R P ^a   Farsky, S H P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Gene expression; INOS activity; L NAME; Lymphocytes; Rats

Indexed keywords

CD31 ANTIGEN; CONSTITUTIVE NITRIC OXIDE SYNTHASE; DRINKING WATER; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY INTERLEUKIN 10; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE SYNTHESIS; IMMUNOMODULATION; MALE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; TRANSCRIPTION INITIATION; WISTAR RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME INHIBITORS; INFLAMMATION; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; LYMPHOCYTES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RANDOM ALLOCATION; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79960060961     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04396.x     Document Type: Article

References (43)

1. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2001; 2:907-16.
2. Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev 2009; 61:62-97.
3. Kröncke KD, Fehsel K, Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 1998; 113:147-56.
4. Farsky SH, Borelli P, Fock RA, Proto SZ, Ferreira JM, Mello SBV. Chronic blockade of nitric oxide biosynthesis in rats: effect on leukocyte endothelial interaction and on leukocyte recruitment. Inflamm Res 2004; 53:442-52.
5. Hebeda CB, Teixeira SA, Muscará MN etal. In vivo blockade of Ca(+2)-dependent nitric oxide synthases impairs expressions of L-selectin and PECAM-1. Biochem Biophys Res Commun 2008; 377:694-8.
6. Newman PJ, Newman DK. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 2003; 23:953-64.
7. Petri B, Bixel MG. Molecular events during leukocyte diapedesis. FEBS J 2006; 273:4399-407.
8. Harry BL, Sanders JM, Feaver RE etal. Endothelial cell PECAM-1 promotes atherosclerotic lesions in areas of disturbed flow in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2008; 28:2003-8.
9. Chen Z, Tzima E. PECAM-1 is necessary for flow-induced vascular remodeling. Arterioscler Thromb Vasc Biol 2009; 29:1067-73.
10. Jackson DE. The unfolding tale of PECAM-1. FEBS Lett 2003; 540:7-14.
11. Ilan N, Madri JA. PECAM-1: old friend, new partners. Curr Opin Cell Biol 2003; 15:515-24.
12. Privratsky JR, Newman DK, Newman PJ. PECAM-1: conflicts of interest in inflammation. Life Sci 2010; 87:69-82.
13. Bagi Z, Frangos JA, Yeh JC, White CR, Kaley G, Koller A. PECAM-1 mediates NO-dependent dilation of arterioles to high temporal gradients of shear stress. Arterioscler Thromb Vasc Biol 2005; 25:1590-5.
14. Fleming I, Fisslthaler B, Dixit M, Busse R. Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells. J Cell Sci 2005; 118:4103-11.
15. Dal Secco D, Moreira AP, Freitas A etal. Nitric oxide inhibits neutrophil migration by a mechanism dependent on ICAM-1: role of soluble guanylate cyclase. Nitric Oxide 2006; 15:77-86.
16. Lin HC, Wang CH, Yu CT, Hwang KS, Kuo HP. Endogenous nitric oxide inhibits neutrophil adherence to lung epithelial cells to modulate interleukin-8 release. Life Sci 2001; 69:1333-44.
17. de Mello SB, Novaes GS, Laurindo IM, Muscará MN, Maciel FM, Cossermelli W. Nitric oxide synthase inhibitor influences prostaglandin and interleukin-1 production in experimental arthritic joints. Inflamm Res 1997; 46:72-7.
18. Mello SB, Guzzo ML, Lisboa LF, Farsky SH. Pharmacological characterisation of arthritis induced by Bothrops jararaca venom in rabbits: a positive cross talk between bradykinin, nitric oxide and prostaglandin E2. Mediators Inflamm 2002; 11:13-16.
19. Korhonen R, Kosonen O, Hämäläinen M, Moilanen E. Nitric oxide releasing compounds inhibit the production of interleukin-2, -4 and -10 in activated human lymphocytes. Basic Clin Pharmacol Toxicol 2008; 103:322-8.
20. Järvinen K, Vuolteenaho K, Nieminen R, Moilanen T, Knowles RG, Moilanen E. Selective iNOS inhibitor 1400W enhances anti-catabolic IL-10 and reduces destructive MMP-10 in OA cartilage. Survey of the effects of 1400W on inflammatory mediators produced by OA cartilage as detected by protein antibody array. Clin Exp Rheumatol 2008; 26:275-82.
21. Menezes GB, Lee WY, Zhou H, Waterhouse CC, Cara DC, Kubes P. Selective down-regulation of neutrophil Mac-1 in endotoxemic hepatic microcirculation via IL-10. J Immunol 2009; 183:7557-68.
22. Kang H, Yang PY, Rui YC. Adenovirus viral interleukin-10 inhibits adhesion molecule expressions induced by hypoxia/reoxygenation in cerebrovascular endothelial cells. Acta Pharmacol Sin 2000; 29:50-6.
23. Jorgensen C, Apparailly F, Couret I, Canovas F, Jacquet C, Sany J. Interleukin-4 and interleukin-10 are chondroprotective and decrease mononuclear cell recruitment in human rheumatoid synovium in vivo. Immunology 1998; 93:518-23.
24. Krakauer T. IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells. Immunol Lett 1995; 45:61-5.
25. Tinsley JH, South S, Chiasson VL, Mitchell BM. Interleukin-10 reduces inflammation, endothelial dysfunction, and blood pressure in hypertensive pregnant rats. Am J Physiol Regul Integr Comp Physiol 2010; 298:713-19.
26. Hiki K, Hattori R, Kawai C, Yui Y. Purification of insoluble nitric oxide synthase from rat cerebellum. J Biochem 1992; 111:556-8.
27. Chen SF, Fei X, Li SH. A new simple method for isolation of microvascular endothelial cells avoiding both chemical and mechanical injuries. Microvasc Res 1995; 50:119-28.
28. Lotufo CM, Yamashita CE, Farsky SH, Markus RP. Melatonin effect on endothelial cells reduces vascular permeability increase induced by leukotriene B4. Eur J Pharmacol 2006; 534:258-63.
29. Tamura EK, Fernandes PA, Marçola M, da Silveira Cruz-Machado S, Markus RP. Long-lasting priming of endothelial cells by plasma melatonin levels. PLoS ONE 2010; 5:e13958.
30. Fujisawa H, Nakagawa S, Ohkubo Y etal. Local and systemic expression of inducible nitric oxide synthase in comparison with that of cyclooxygenase-2 rat carrageenin-induced pleurisy. Nitric Oxide 2005; 12:80-8.
31. Tripathi P, Tripathi P, Kashyap L, Singh V. The role of nitric oxide in inflammatory reactions. FEMS Immunol Med Microbiol 2007; 51:443-52.
32. Pietrzak A, Misiak-Tłoczek A, Brzezińska-Błaszczyk E. Interleukin (IL)-10 inhibits RANTES-, tumour necrosis factor (TNF)- and nerve growth factor (NGF)-induced mast cell migratory response but is not a mast cell chemoattractant. Immunol Lett 2009; 24:46-51.
33. Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol 2008; 180:5771-7.
34. den Haan JM, Kraal G, Bevan MJ. Cutting edge: lipopolysaccharide induces IL-10-producing regulatory CD4+ T cells that suppress the CD8+ T cell response. J Immunol 2007; 178:5429-33.
35. Grütz G. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol 2005; 77:3-15.
36. Tumurkhuu G, Koide N, Dagvadorj J etal. B1 cells produce nitric oxide in response to a series of toll-like receptor ligands. Cell Immunol 2010; 261:122-7.
37. Denham S, Rowland IJ. Inhibition of the reactive proliferation of lymphocytes by activated macrophages: the role of nitric oxide. Clin Exp Immunol 1992; 87:157-62.
38. van der Veen RC. Nitric oxide and T helper cell immunity. Int Immunopharmacol 2001; 1:1491-500.
39. Shuler RL, Laskin DL, Gardner CR, Feder LS, Laskin JD. Lymphocyte-mediated nitric oxide production by rat endothelial cells. J Leukoc Biol 1995; 57:116-21.
40. Van Der Meeren A, Squiban C, Gourmelon P, Lafont H, Gaugler MH. Differential regulation by IL-4 and IL-10 of radiation-induced IL-6 and IL-8 production and ICAM-1 expression by human endothelial cells. Cytokine 1999; 11:831-8.
41. Morise Z, Eppihimer M, Granger DN, Anderson DC, Grisham MB. Effects of lipopolysaccharide on endothelial cell adhesion molecule expression in interleukin-10 deficient mice. Inflammation 1999; 23:99-110.
42. Kawachi S, Jennings S, Panes J etal. Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice. Am J Physiol Gastrointest Liver Physiol 2000; 278:734-43.
43. Garnacho C, Albelda SM, Muzykantov VR, Muro S. Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes. J Control Release 2008; 130:226-33.